Illustrates data on substance use treatment in Ontario in 2017–2018.
The Mental Health for All (MH4A) Conference plays a unique role in uniting the people and ideas that exemplify mental health in Canada.
Summarizes four important facts currently known about COVID-19 and how it can affect people who smoke or vape cannabis products.
Summarizes data on the use of cocaine, including the harms and effects, legal status and access to treatment. The prevalence of cocaine use was two per cent among people living in Canada in 2019.
One-page poster highlighting the health risks associated with using stimulants, including methamphetamine and cocaine, during the COVID-19 pandemic. Also provides practical tips to reduce the spread of COVID-19 if using stimulants.
Examines the regulatory frameworks implemented for the legalization of cannabis in Colorado and Washington State.
Outlines the continuum of care to provide quality treatment for youth who experience harm from psychoactive prescription drugs.
Outlines the continuum of care to provide quality treatment for youth who experience harm from psychoactive prescription drugs.
This policy brief presents the key issues for minimizing the harms associated with cannabis-impaired driving. It provides policy makers with information to assist in developing evidence-informed policy about cannabis and driving.
Created in partnership with Inuit Tapiriit Kanatami, the national organization representing Inuit across Canada, this technical report synthesizes statistics on mental health, substance use and the social determinants of health that influence…
Presents trends of cannabis use among young people in Nova Scotia, including prevalence of use, perceptions of harm, cannabis use and driving, and dimensions of risk.
